IMI is pleased to announce that we have entered into an Exclusive Distribution Agreement with Canadian Hospital Specialties Ltd. (CHS) for all IMI products offered in Canada. Through this partnership, IMI will extend its reach into the Canadian market with a company that has been long recognized as a primary medical supply resource to the Canadian health system. Since 1967, the CHS has grown to over 300 employees including a National sales and marketing team of 40 individuals focused on the key areas of their business. As a result of this agreement, all direct IMI customers located in Canada will be serviced by CHS effective January 1st 2019. These valued customers will now have all the advantages that only an in-nation supplier can provide.
IMI (International Medical Industries, Inc.) bolsters expertise in secure drug delivery products with the release of their Prep-Lock Tamper Evident Cap for IV Syringes with incorporated Radio Frequency Identification (RFID) technology.
The Staggering Cost of DiversionA recent study published in the Journal of Hospital Medicine cited the vast costs diversion poses for Health Systems. “Hospitals bear the cost of diverted drugs, internal investigations, and follow-up care for affected patients, and can...
IMI brings expertise in Tamper Evident Security to the home health market through a strategic partnership with
Integrated Medical Systems, Inc. (IMS), a leading national distributor within the alternate site marketplace. The
collaboration introduces IMI products to home infusion healthcare furthering drug integrity and security from
pharmacy to patient